IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Proteomic Expression Signature Distinguishes Cancerous and Nonmalignant Tissues in Hepatocellular Carcinoma
Lee, Nikki P.1; Chen, Lei1,3; Lin, Marie C.2; Tsang, Felice H.1; Yeung, Chun1; Poon, Ronnie T.1; Peng, Jirun3; Leng, Xisheng3; Beretta, Laura4; Sun, Stella1; Day, Philip J.5; Luk, John M.1
关键词hepatocellular carcinoma tumor markers proteomics diagnosis and prognosis
刊名JOURNAL OF PROTEOME RESEARCH
2009-03-01
DOI10.1021/pr800637z
8期:3页:1293-1303
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biochemical Research Methods
研究领域[WOS]Biochemistry & Molecular Biology
关键词[WOS]HEAT-SHOCK PROTEINS ; CATHEPSIN-B ; ALPHA-FETOPROTEIN ; PROGESTERONE-RECEPTOR ; CLINICAL-IMPLICATIONS ; CHRONIC HEPATITIS ; CYTOCHROME B(5) ; LIVER-CIRRHOSIS ; SERUM ; MARKER
英文摘要

Hepatocellular carcinoma (HCC) is an aggressive liver cancer but clinically validated biomarkers that can predict natural history of malignant progression are lacking. The present study explored the proteome-wide patterns of HCC to identify biomarker signature that could distinguish cancerous and nonmalignant liver tissues. A retrospective cohort of 80 HBV-associated HCC was included and both the tumor and adjacent nontumor tissues were subjected to proteome-wide expression profiling by 2-DE method. The subjects were randomly divided into the training (n = 55) and validation (n = 25) subsets, and the data analyzed by classification-and-regression tree algorithm. Protein markers were characterized by MALDI-ToF/MS and confirmed by immunohistochemistry, Western blotting and qPCR assays. Proteomic expression signature composed of six biomarkers (haptoglobin, cytochrome b5, progesterone receptor membrane component 1, heat shock 27 kDa protein 1, lysosomal proteinase cathepsin B, keratin 1) was developed as a classifier model for predicting HCC. We further evaluated the model using both leave-one-out procedure and independent validation, and the overall sensitivity and specificity for HCC both are 92.5%, respectively. Clinical correlation analysis revealed that these biomarkers were significantly associated with serum AFP, total protein levels and the Ishak′s score. The described model using biomarker signatures could accurately distinguish HCC from nonmalignant tissues, which may also provide hints on how normal hepatocytes are transformed to malignant state during tumor progression.

语种英语
WOS记录号WOS:000264035000019
项目编号N_HKU 718/03 ; ITS/120/07
资助机构Council of Hong Kong ; Innovation and Technology Fund ; Sun Chieh Yeh Research Foundation for Hepatobiliary and Pancreatic Surgery
引用统计
被引频次:47[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63967
专题北京大学第二临床医学院
作者单位1.Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
2.Univ Hong Kong, Dept Surg, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China
3.Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China
4.Peking Univ, Dept Surg, Peoples Hosp, Beijing 100871, Peoples R China
5.Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England
推荐引用方式
GB/T 7714
Lee, Nikki P.,Chen, Lei,Lin, Marie C.,et al. Proteomic Expression Signature Distinguishes Cancerous and Nonmalignant Tissues in Hepatocellular Carcinoma[J]. JOURNAL OF PROTEOME RESEARCH,2009,8(3):1293-1303.
APA Lee, Nikki P..,Chen, Lei.,Lin, Marie C..,Tsang, Felice H..,Yeung, Chun.,...&Luk, John M..(2009).Proteomic Expression Signature Distinguishes Cancerous and Nonmalignant Tissues in Hepatocellular Carcinoma.JOURNAL OF PROTEOME RESEARCH,8(3),1293-1303.
MLA Lee, Nikki P.,et al."Proteomic Expression Signature Distinguishes Cancerous and Nonmalignant Tissues in Hepatocellular Carcinoma".JOURNAL OF PROTEOME RESEARCH 8.3(2009):1293-1303.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Lee, Nikki P.]的文章
[Chen, Lei]的文章
[Lin, Marie C.]的文章
百度学术
百度学术中相似的文章
[Lee, Nikki P.]的文章
[Chen, Lei]的文章
[Lin, Marie C.]的文章
必应学术
必应学术中相似的文章
[Lee, Nikki P.]的文章
[Chen, Lei]的文章
[Lin, Marie C.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。